Form 483

Fresenius Kabi USA, LLC Form 483, 2016-02-04

FDA issued a Form 483 to Fresenius Kabi USA, LLC on 2016-02-04 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Fresenius Kabi USA, LLC · Grand Island, United States · Issued February 4, 2016

Overview

  • 5 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Feb 2016
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Patric C Klotzbuecher, Charanjeet Jassal

4 Feb 2016
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Patric C Klotzbuecher, Charanjeet Jassal

4 Feb 2016
21 CFR 211.192

Quality control unit review of records

Cited by Patric C Klotzbuecher, Charanjeet Jassal

4 Feb 2016
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Patric C Klotzbuecher, Charanjeet Jassal

4 Feb 2016
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Patric C Klotzbuecher, Charanjeet Jassal

Inspected site

FKFresenius Kabi USA, LLCGrand Island, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere